AJP Legacy Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 205: 235-240, 1963;
0002-9513/63 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burford, H.
Right arrow Articles by Huggins, C. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burford, H.
Right arrow Articles by Huggins, C. G.

Metabolism of phosphorus in the supersensitive submaxillary gland of the cat

H. Burford 1 and C. G. Huggins 1

1 Department of Pharmacology, University of Kansas Medical Center, Kansas City, Kansas, and Department of Biochemistry, Tulane University School of Medicine, New Orleans, Louisiana

We have used the supersensitive submaxillary gland of the cat to investigate the relationship between secretory phenomena and phosphorus metabolism, in vivo. Supersensitivity was produced by surgical removal of a 1 cm section of the chorda tympani nerve or by chronic administration (15 days, s.c.) of 1, 1-diphenyl-4-N-piperidinobutyramide (Hö 9980). After subcutaneous injection of radiophosphorus, secretion was induced by administration of epinephrine or acetylcholine over a 2-hr experimental period. Analyses for phosphorus and radioactivity on the different phosphorus-containing fractions have shown that there was an increase in the specific activity of the phosphatido-peptide and phospholipid fractions obtained from the supersensitive gland. No increase was apparent in the radioactivity in the total acid-soluble or 7-min hydrolyzable fractions. The increase in metabolic activity of the phosphatido-peptide and phospholipid fractions was found to be blocked when atropine or dihydroergotamine were used to inhibit secretion. We interpret our findings as supporting evidence for the participation of these two fractions in secretion of saliva in a manner not yet understood.

Submitted on August 27, 1962







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1963 by the American Physiological Society.